Blue diode laser vaporization treatment for symptomatic benign prostatic hyperplasia in men aged 50 and older

What this Trial Is About

This research aims to evaluate the outcomes of using a blue diode laser vaporization procedure to treat benign prostatic hyperplasia BPH in men aged 50 and older. The study follows a single group of participants over one year to observe how this 450nm blue laser treatment affects symptoms and prostate function. Researchers are collecting detailed data to understand the clinical progress and safety of this approach under medical supervision. Participants will receive the blue diode laser vaporization treatment performed under spinal or general anesthesia using a 200W blue light laser. Follow-up visits are scheduled at 3 months, 6 months, and 12 months after the operation to monitor recovery and treatment effects. During these visits, various tests and questionnaires will be repeated to assess prostate size, urinary flow, symptoms, and quality of life. Throughout the study, participants will undergo blood and urine tests, ultrasound scans to measure prostate volume, and uroflowmetry to check urine flow. The International Prostate Symptom Score IPSS and other questionnaires will be used to evaluate symptoms and quality of life. Researchers will also monitor any adverse events, unplanned hospital admissions, and changes in erectile and ejaculatory function. The total time commitment for each participant is one year from treatment to final follow-up.

Blue Diode Laser Vaporization for BPH